The only solution they propose is to depend on anti-diabetic medicines for the rest of one’s life. Some also agree that regular physical activity and strict diets may help to an extent.

Several Indian manufacturers started working on the generic versions of the medicine. "We were expecting prices of anti-diabetic medicine Empagliflozin to crash as the medicine went off patent ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

A large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of ...

Health and Human Services Secretary Robert F. Kennedy Jr. has been critical of the drugs, instead placing a focus on ...

finds that people with type 2 diabetes who take two common anti-diabetes medications had a reduced risk of Alzheimer’s and associated dementias. Specifically, GLP-1RA was linked to a 33% lower ...

The CMS has opted not to move forward with a plan that would have extended Medicare coverage to obesity drugs for millions of Americans.

Doctors have explained the potential pros and cons of these so-called 'skinny jabs', with everything from nausea to abdominal ...

Experts say 85% price drop in empagliflozin expected to boost SGLT2 usage; SGLT-2 class of drugs account for 25-30% of all diabetes prescriptions ...

FDC drugs are those that contain a combination of two or more active pharmaceutical ingredients in a fixed ratio and are also ...

The only solution they propose is to depend on anti-diabetic medicines for the rest of one's life. Some also agree that regular physical activity and strict diets may help to an extent. However, the ...